Perbedaan Organon Pharma Indonesia Tbk. dan Wijaya Karya Beton Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Wijaya Karya Beton Tbk. diperdagangkan di Rp79 (kapitalisasi pasar 688,52 M, volume 24 jam 1,73 jt). Perbedaan utamanya: Wijaya Karya Beton Tbk. jauh lebih besar — sekitar 6,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WTON | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 688,52 M |
Volume | — | 1,73 jt |
Lot | — | 17,3 rb |
Perputaran | — | 135,53 jt |
Harga Rata-rata | — | 78,34 |
Nilai Transaksi | — | 135,53 jt |
Harga Ekuilibrium Indikatif | — | 79 |
Volume Ekuilibrium Indikatif | — | 103 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT. Wijaya Karya Beton (the Company), to hereafter with Wika Beton, was esthablished in Jakarta with the deed of a limited liability company PT Wijaya Karya Beton No 44 dated March 11, 1997 (Act No 44), made in the presence of Achmad Bajuri, SH, as successor of the Imas Fatimah, SH, notary in Jakarta PT Wijaya Karya Beton operational activities started since March 11, 1997
Selengkapnya di halaman WTON →